The effects of autoflow management on flow-rate alerts, collection efficiency, and collection rate during plateletpheresis.

Autoflow management Collection efficiency Collection rate Plateletpheresis

Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 07 2020
revised: 05 08 2020
accepted: 06 08 2020
pubmed: 5 9 2020
medline: 6 8 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

In 2018, Trima Accel software version 6.4 with autoflow management released in China. The purpose of this retrospective study was to evaluate the effects of autoflow management on plateletpheresis procedures, specifically concerning flow-rate alerts, collection efficiency (CE), and collection rate (CR). A total of 2526 procedures using Trima Accel version 6.4 from Nov 2018 to Jan 2019 were included as the test arm in this study. Another 2043 procedures using version 5.1.9 from Nov 2017 to Jan 2018 were included as the control arm. We compared the low-flow alerts and no-flow alerts, collection efficiency (CE), and collections rate (CR) between the two study arms. Also, we analyzed the incidence of autoflow increases and autoflow decreases of version 6.4. The incidence of low-flow alerts for test and control was 16.6 % and 55.3 %(χ Autoflow management shows significant advantages in reducing alerts and subsequent manual intervention. We observe a higher CR and CE using Trima Accel version 6.4 than version 5.1.9, which leads to a more efficient platelet collection.

Sections du résumé

BACKGROUND BACKGROUND
In 2018, Trima Accel software version 6.4 with autoflow management released in China. The purpose of this retrospective study was to evaluate the effects of autoflow management on plateletpheresis procedures, specifically concerning flow-rate alerts, collection efficiency (CE), and collection rate (CR).
METHODS METHODS
A total of 2526 procedures using Trima Accel version 6.4 from Nov 2018 to Jan 2019 were included as the test arm in this study. Another 2043 procedures using version 5.1.9 from Nov 2017 to Jan 2018 were included as the control arm. We compared the low-flow alerts and no-flow alerts, collection efficiency (CE), and collections rate (CR) between the two study arms. Also, we analyzed the incidence of autoflow increases and autoflow decreases of version 6.4.
RESULT RESULTS
The incidence of low-flow alerts for test and control was 16.6 % and 55.3 %(χ
CONCLUSION CONCLUSIONS
Autoflow management shows significant advantages in reducing alerts and subsequent manual intervention. We observe a higher CR and CE using Trima Accel version 6.4 than version 5.1.9, which leads to a more efficient platelet collection.

Identifiants

pubmed: 32883592
pii: S1473-0502(20)30228-7
doi: 10.1016/j.transci.2020.102914
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102914

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Qing Feng (Q)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China; Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, 310052, China. Electronic address: fengqing6050@zjb.org.cn.

Jian Xu (J)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China; Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, 310052, China.

Chunyan Li (C)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China; Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, 310052, China.

Xiahua Zhan (X)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China.

Yue Zheng (Y)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China.

Jun Ye (J)

Blood Center of Zhejiang Province, Hangzhou, Zhejiang, 310006, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH